JENNIFER CREEDON: Open Payments
NPI 1598081879 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 28 payments from 9 companies in 2025. Trend: 2023 $347 · 2024 $364 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $177 |
| Supernus Pharmaceuticals, Inc. | 5 | $175 |
| Otsuka America Pharmaceutical, Inc. | 5 | $80 |
| Indivior Inc. | 2 | $56 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
Products named: Qelbree, ARISTADA, ABILIFY ASIMTUFII, SUBLOCADE, SPRAVATO, ABILIFY MAINTENA, COBENFY, FANAPT.
Industry payments across LA — which companies pay providers there.
